Alzheimer's drugs may have adverse side effects
Alzheimer's disease drugs now being tested in clinical trials may have potentially adverse side effects, according to new Northwestern Medicine research. A study with mice suggests the drugs could act like a bad electrician, causing neurons to be miswired and interfering with their ability to send messages to the brain....
Source: PhysOrg - Saturday, 18 February
Related articles:
- Older News
- 5Vote! Gene-modified stem cell transplant protects patients from toxic side effects of chemotherapy
LabSpaces - Thursday, 10 May
- 4Vote! Scientists gain new understanding of Alzheimer's trigger
e! Science News - Wednesday, 2 May
- 7Vote! Alzheimer's plaques disrupt brain networks
- 2Vote! Another Side to Statins
ScienceNews - Friday, 20 April
- 5Vote! Alzheimer's precursor protein controls its own fate, study finds
- 3Vote! Bioengineers develop artificial chip for testing how drugs interact with ion channels
PhysOrg - Tuesday, 10 April
- 4Vote! Researchers identify drugs with fewest side-effects for treating irritable bowel syndrome
- 6Vote! Researchers boost potency, reduce side effects of IL-2 protein used to treat cancer
- 6Vote! Common medicines may cut cancer drug potency: study
- 10Vote! Scientists discover drug side effects, interactions using new computer algorithm
- 6Vote! Protein researchers unravel the molecular dance of DNA repair
- 6Vote! Regulator protein plays double duty
Futurity.org - Wednesday, 14 March
- 8Vote! Planning for the future: unemployment and its effects on future generations
- 5Vote! Discovery could reduce chemo's side effects
- 5Vote! Reversing Alzheimer's gene 'blockade' can restore memory, other cognitive functions
- 8Vote! Blockade of learning and memory genes may occur early in Alzheimer's disease
- 6Vote! New Alzheimer’s drugs botch brain’s wiring
- 6Vote! A mechanism to improve learning and memory
- 7Vote! Alzheimer's Drug May Impair Memory
(LiveScience.com)
Yahoo Science News - Monday, 20 February
- 7Vote! Mapping of protein inhibitors facilitates development of tailor-made anticancer agents
